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Abstract
Axon regeneration in the CNS is inhibited by many extrinsic and intrinsic factors. Because these act in parallel, no single 
intervention has been sufficient to enable full regeneration of damaged axons in the adult mammalian CNS. In the external 
environment, NogoA and CSPGs are strongly inhibitory to the regeneration of adult axons. CNS neurons lose intrinsic 
regenerative ability as they mature: embryonic but not mature neurons can grow axons for long distances when transplanted 
into the adult CNS, and regeneration fails with maturity in in vitro axotomy models. The causes of this loss of regeneration 
include partitioning of neurons into axonal and dendritic fields with many growth-related molecules directed specifically to 
dendrites and excluded from axons, changes in axonal signalling due to changes in expression and localization of receptors 
and their ligands, changes in local translation of proteins in axons, and changes in cytoskeletal dynamics after injury. Also 
with neuronal maturation come epigenetic changes in neurons, with many of the transcription factor binding sites that drive 
axon growth-related genes becoming inaccessible. The overall aim for successful regeneration is to ensure that the right 
molecules are expressed after axotomy and to arrange for them to be transported to the right place in the neuron, including 
the damaged axon tip.
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Abbreviations
ACAP1  Arf-GAP with coiled-coil, ANK repeat and PH 
domain-containing protein 1
Arf6  ADP ribosylation factor 6
CS-GAG  Chondroitin sulphate glycosaminoglycan
CSPG  Chondroitin sulphate proteoglycan
DLK-1  Mitogen-activated protein kinase kinase kinase 
dlk-1
Efa6  Exchange factor for Arf6
FAK  Focal Adhesion Kinase
GAP  GTPase activating protein
GEF  Guanyl-nucleotide exchange factor
JIP  C-Jun-amino-terminal kinase-interacting 
protein
KLF  Kruppel-like factor
MAG  Myelin-associated glycoprotein
Neu7  Membrane ganglioside Sialidase 7
OEG  Olfatory ensheathing glia
OMgp  Oligodenrocyte myelin glycoprotein
PIP3  Phosphatidylinositol (3,4,5)-trisphosphate
Rab11  Ras-related protein Rab11
Trk  Tropomyosin-related kinase (neurotrophin 
receptor
History
Axon regeneration in the form of peripheral nerve repair has 
been in clinical practice since the 12th Century and possibly 
before, but spinal cord injury has been recognized as incur-
able since ancient times [14]. Cajal made several studies of 
regeneration in the PNS and its failure in the CNS, and was 
responsible with Tello for the first CNS regeneration experi-
ment, implanting a graft of peripheral nerve into the CNS 
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[106]. Yet we still do not have a solution for a clinically use-
ful axon regeneration treatment. This stimulated a memora-
ble introduction to a spinal injury research meeting by David 
Allan, director of the Scottish spinal injury unit, in which he 
challenged the audience,“the first regeneration experiment 
by Tello and Cajal was over 100 years ago, but we still do 
not have a treatment for our patients. What have you all been 
doing?”. Working out how to stimulate useful CNS axon 
regeneration has been extremely difficult, but recent progress 
has produced several interventions that enable partial regen-
eration, and increasing understanding of the biology gives 
reasonable optimism that a solution will be found soon. For 
many years research proceeded on the assumption that there 
might be a single straightforward fix for CNS regeneration. 
Peripheral nerves regenerate, and regeneration after axotomy 
in the CNS is generally successful in lower vertebrates and 
invertebrates, so surely the solution to lack of regeneration 
in the mammalian CNS should be straightforward. Sadly this 
is not so. It is now clear that evolution has gone to consider-
able lengths and developed several mechanisms to turn off 
regeneration and plasticity in the adult mammalian CNS. 
Restoring regeneration and plasticity is therefore complex, 
and several inhibitory mechanisms have to be addressed. 
Clearly there must be evolutionary advantages in turning off 
these developmental processes in adulthood. It may be that 
a hard-wired nervous system is more efficient, or the ener-
getics or potential for mutation of maintaining regeneration 
and plasticity may be unfavourable, or there may be issues 
related to control of inflammation. Whatever the cause, we 
are now at the stage where the biology of regeneration fail-
ure is increasingly understood and solutions are being found. 
This review gives an overview of the current position.
The Inhibitory CNS Environment
The fact that regeneration succeeds in peripheral nerves and 
fails in the CNS gives an obvious hypothesis that the PNS 
environment is permissive, the CNS is inhibitory. This idea 
was supported by Tello and Cajal’s grafting experiment, and 
further supported when Aguayo and his colleagues grafted 
peripheral nerves into the CNS and traced regenerating 
axons using modern methods [34, 43]. Clearly some CNS 
axons, particularly if their cell body is close to the graft, 
can regenerate axons into a permissive PNS environment. 
Grafting either nerves or permissive glia into the damaged 
spinal cord is therefore a method for enabling axon regen-
eration and for bridging a lesion cavity. Schwann cells have 
the advantage that they can readily be obtained from nerve 
explants from individual patients and expanded in tissue 
culture. Many animal experiments showed that spinal cord 
axons could regenerate into these grafts. However Schwann 
cells tend to be excluded from mixing with CNS glia by a 
reactive wall of astrocytes, and regenerating axons are inhib-
ited at this point [1], so they rarely re-enter CNS tissue to re-
connect to CNS neurons. This issue has been addressed by 
treating the lesion area with a phosphodiesterase inhibitor to 
raise cAMP [46, 60, 101], and by injection of chondroitinase 
ABC to digest the inhibitory CSPGs at the Schwan cell-
astrocyte boundary. A clinical trial of autologous Schwann 
cell transplantation to human spinal cord injury patients is 
currently under way [3]. An alternative to Schwann cells 
are olfactory ensheathing glia (OEGs). The rationale is that 
the axons that constantly grow from newly born olfactory 
receptors are introduced into the CNS by these cells, which 
open the astrocyte boundary to enable them to enter the CNS 
environment. Transplantation in animal models led to suc-
cessful regeneration and recovery [80], so a trial in human 
patients was initiated. Obtaining OEGs from human patients 
is more difficult than Schwann cells. Cells can be harvested 
from olfactory mucosal biopsies and proliferated to some 
extent, but the number of cells is limiting and mucosal-
derived OEGs are not good a promoting axon regeneration 
[65]. An operation to obtain bulbar OEGs through an orbital 
route was developed, and a trial of this method in a patient 
was accompanied by sufficient sensory and motor recovery 
that further experimental treatments are planned [127].
Various other permissive cell types have been grafted into 
the spinal cord, including embryonic tissue, glial cells and 
stem cell types enabling some regeneration and functional 
recovery. Bone marrow stem cells have been widely used to 
protect and stimulate regeneration. Implanted into the spinal 
cord or introduced via blood vessels these cells have been 
neuroprotective, have improved functional recovery and in 
many cases stimulated regeneration of spinal axons [7, 33, 
110, 117, 136]. The promising animal results led to a clini-
cal study in which autologous cells were infused via a local 
spinal artery: the study demonstrated safety and good recov-
ery in some patients, but no overall statistically significant 
improvement [126].
A remarkable advance has been the stimulation of regen-
eration of host axons by implants of embryonic spinal cord 
or spinal cord progenitors. Embryonic CNS tissue of the 
right stage is clearly permissive to axon growth, because it 
supports axonal ingrowth and formation of connections as 
part of normal development. Embryonic spinal cord trans-
plants into the adult spinal cord attracted ingrowth of spinal 
cord axons from various neuronal types, and occasionally 
growth through the graft and out the other side back into the 
host cord [17, 108]. Axon ingrowth was greater in newborn 
animals, and there was also some specificity in that axons 
would not generally grow into non-target embryonic tissue 
such as hippocampus [16, 17]. The idea of foetal transplanta-
tion has recently been revived with improved methods and 
embryonic progenitor cells rather than whole transplants. 
The host-graft interface and the survival of cells has been 
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improved by embedding the transplant in a fibrin/collagen 
gel containing multiple growth factors, and improved meth-
ods for progenitor production and characterisation and trac-
ing of connections has enabled new levels of analysis. When 
the grafts are of spinal cord origin and the correct embryonic 
developmental state, prolific ingrowth of neurites is seen 
[85]. Of particular interest is the extensive ingrowth of fibres 
from the corticospinal tract, which is usually refractory to 
regeneration but able to sprout extensively after axotomy. It 
is not clear if the innervation of the grafts is very extensive 
sprouting or long-distance regeneration, but the processes 
are able to make many synaptic connections. Particularly 
exciting is the finding that the ingrowing axons show great 
specificity in the connections that they make with graft neu-
rons. The injured motor and sensory axons reconnect with 
appropriate graft neurons, choosing neuronal types that nor-
mally receive either sensory or motor inputs [37], and even 
within the connections of corticospinal axons, the processes 
connect very precisely to the types of spinal interneuron that 
would normally receive corticospinal inputs [73]. Over time 
the graft neurons mature to express markers associated with 
adult neurons. It is not clear what the guidance mechanisms 
here would be, but clearly regenerating adult axons are able 
to select very precisely the correct type of neuronal target. 
These same neuronal types are able to grow axons that exit 
the graft and can grow for considerable distances down the 
host spinal cord, making connections with host neurons (see 
later). These embryonic grafts are therefore able to function 
as relays, receiving regenerated host axons as inputs and 
sending connections back to the host distal to the injury as 
projections. This relay behaviour is presumably the foun-
dation of the ability of the grafts to restore function to the 
injured spinal cord.
The concept of the inhibitory CNS post-injury environ-
ment dominated research into CNS regeneration for many 
years. This work has been reviewed many times, so a brief 
account appears below. A number of inhibitory molecules 
are present in the CNS environment, some of them upregu-
lated or released after injury. The main inhibitors are NogoA 
which is present on oligodendrocytes, chondroitin sulphate 
proteoglycans (CSPGs) are produced mainly by glia, myelin-
associated glycoprotein (MAG) is produced by myelinating 
glia, Oligodendrocyte myelin glycoprotein (OMgp) by oli-
godendrocytes, semaphorin 3A mainly by perivascular and 
meningeal cells and tenascin-C from astrocytes [44]. The 
majority of research in this area has focused on NogoA and 
its receptor and CSPGs. Blocking the effects of NogoA with 
an antibody enabled regeneration and functional recovery 
in rodent and monkey models of spinal injury [118] and 
a phase 1 clinical trial has been completed with phase 2 
planned to start soon. The Nogo receptor has been a focus, 
which is acted upon by NogoA, MAG and OMgp and signals 
via RhoA. Many animal studies of receptor knockouts and 
blockers have shown regeneration and functional recovery, 
and a receptor decoy is planned to enter early stage human 
trials [141]. CSPGs are upregulated around CNS injuries, 
produced mainly by astrocytes and oligodendrocyte pre-
cursors. There are several CSPG core proteins, all bear-
ing serine-linked sulphated glycosaminoglycan (CS-GAG) 
chains. It is the CS-GAG chains that are the main source 
of inhibition of axon regeneration, so most studies have 
focused on digesting these with the bacterial enzyme chon-
droitinase ABC. CS-GAG digestion, inhibition of synthesis 
or blockade of the PTPσ CS-GAG receptor have all led to 
some axon regeneration and also functional recovery [23, 24, 
134], although the functional recovery may be mainly due 
to the reactivation of plasticity that comes with removing 
CSPGs from perineuronal nets around GABAergic inhibi-
tory neurons [123]. A trial of chondroitinase ABC treatment 
in canine patients with spinal cord injury demonstrated a 
useful restoration of walking and standing function [62]. The 
overall observation from neutralizing or removing inhibitory 
molecules or their receptors is that some axon regeneration 
and sprouting can be enabled together with reactivation of 
plasticity, but the axon regeneration is a long way short of 
complete repair. Some axons may regenerate sufficiently to 
cross a small lesion, and having done so they may connect 
to interneurons allowing their influence to be relayed down 
the spinal cord. None of the inhibitory molecules are abso-
lute blockers of regeneration, and an excess of permissive 
molecules or axons with high growth potential will enable 
axon regeneration in their presence [4]. Treatments targeted 
at inhibitory molecules can certainly form part of a treatment 
for spinal cord injury, with their effect on promoting plas-
ticity being particularly helpful in functionally incomplete 
lesions. By themselves these treatments can be expected to 
promote partial recovery of function after CNS damage, but 
they will not be sufficient for complete recovery.
Intrinisic Control of Regeneration
In the years following the experiments from the Aguayo 
laboratory that demonstrated that the CNS environment is 
inhibitory for axon regeneration, the focus of research was 
on inhibitory molecules. Axons were assumed to be enabled 
by a permissive environment or blocked by an inhibitory 
one. Thus the reason why axons would regenerate in periph-
eral nerves and not the spinal cord was thought to be due to 
the environment rather than the properties of the axons. It 
became apparent that this was a much too simplistic view, 
and that different types of axon have very different abilities 
to grow and regenerate. The first evidence for this came from 
the study of embryonic CNS tissue grafted into the adult 
CNS. If the embryonic neurons were grafted at around the 
stage of maturity when they would normally be growing 
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axons within the embryo, then axons from these grafts could 
grow for long distances through the supposedly inhibitory 
adult CNS, overcoming inhibition from the many inhibi-
tory molecules. Thus grafts of spinal cord, striatum, sub-
stantia nigra, hippocampus could all send out axons into the 
adult CNS, and in many cases there was evidence that these 
axons could synapse with host neurons [108, 124, 146]. If 
the grafts came from human embryos, where axons continue 
to grow over a longer period than in the rodent CNS, then 
the axonal growth was particularly profuse [143]. Thus it 
appeared that axons growing from embryonic neurons were 
not subject to the inhibitory influences that could prevent 
regeneration of cut adult axons. A second example came 
from studying regeneration of the central and peripheral 
branches of sensory axons. The peripheral branch regener-
ates vigorously, restoring function in experimental animals 
and human patients. The central branch passes through the 
dorsal root, which is peripheral nerve territory containing 
Schwann cells and should therefore be permissive. Yet after 
dorsal root crushes the central branch shows a much less 
vigorous regenerative response that the peripheral branch 
[32]. Even within the adult CNS it became clear that some 
pathways such as the nigrostriatal tract have a relatively high 
ability to regenerate while others such as the corticospinal 
tract are very poor regenerators [22]. Studies of regenera-
tion in the PNS revealed that peripheral axotomy initiates 
a programme of changes of gene expression with upregu-
lation of a set of molecules termed RAGS (regeneration-
associated molecules), while cutting CNS axons led to little 
or no upregulation of RAGS in their neurons [66, 91]. It 
was also possible to stimulate regeneration of CNS axons to 
some degree by treatment with an appropriate neurotrophin 
to stimulate the axon and neuron [51, 130]. Together, these 
and other observations started to shift the balance of activity 
of CNS regeneration research towards the intrinsic regenera-
tive properties of neurons and their axons: current research 
in this area is described below.
Neurons Lose Regenerative Ability as They 
Mature
As described above, embryonic neurons transplanted into 
the adult CNS will usually grow axons within the adult host 
CNS. When the grafts are taken from embryonic basal fore-
brain or striatum the neurons are typically at the stage at which 
they are growing axons in the embryo, and their processes 
are mostly cut or stripped off during the preparation, so the 
process growth is regeneration [18, 122]. However transplants 
of embryonic spinal cord progenitors from E14 rats or spinal 
cord-directed neural precursors differentiated from stem cells, 
transplanted before final differentiation and process outgrowth, 
are also able to grow prolific axonal projections that travel 
most of the length of a rat spinal cord or, in the case of human 
spinal precursors grafted into non-human primates, for up to 
50 mm [85, 98, 113]. Thus embryonic neurons committed to 
differentiate into cells appropriate for their graft site have a 
remarkable ability to grow their axons into adult host CNS. 
This growth occurs in both white and grey matter, and appears 
to be little influenced by the inhibitory molecules that block 
regeneration by mature adult axons. There is a clear develop-
mental window during which grafted cells will grow axons 
into adult host CNS, which ends as the neurons start to make 
connections in the embryo: intrinsic regenerative ability is lost 
with neuronal maturation. The axons make synaptic connec-
tions with many types of host spinal neuron, including moto-
neurons [86]. Over time the neurons mature and express adult 
neuronal markers [84]. The ability of grafted spinal cord and 
other CNS neurons to grow neurites into the adult host CNS 
is restricted to embryonic neurons at the appropriate develop-
mental stage (generally before they have formed synapses). 
However sensory neurons, which retain the ability to regener-
ate their axons into adulthood, also retain the ability to grow 
axons when grafted into the adult spinal cord [35].
Changes in axon growth with maturity can be reproduced in 
tissue culture models. Retinal ganglion cells lose their ability 
to grow axons with maturity as a result of signals from the ret-
ina and retinal amacrine cells [50]. Cortical neurons cultured 
from E18 rats are at the developmental stage when growth of 
projection axons into the spinal cord and other brain regions 
is starting. When these neurons are placed into culture they 
quickly grow dendrites and an axon, and if the axon is then 
cut with a laser it regenerates in around 80% of cases. Over 
the ensuing weeks the neurons grow long processes, develop 
many synapses, become spontaneously electrically active and 
undergo gene expression changes to an adult pattern. When 
the axons of these mature neurons are cut the percentage that 
regenerate becomes progressively smaller with maturity [71]. 
The axons of mature DRG neurons continue to regenerate 
when cut, as in vivo, but the mode of growth changes from 
long straight axons to multiple branches [129].
Why do neurons lose axon regeneration as they mature? 
Research has focused on two areas, the axons themselves 
and the genetic and epigenetic changes that drive changes 
in the molecules present in the neurons. The two approaches 
are obviously linked, and axonal changes must be driven by 
changes in gene expression, but the research questions are 
easier to discuss separately.
Axonal Mechanisms
The Axonal Surface
Axons communicate with their environment through cell 
surface adhesion, receptor, channel and mechanosensitive 
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molecules, and any axon growth must involve a dialogue 
with the environment via the surface. Key molecules are 
cell surface adhesion molecules which enable growing axons 
to exert traction on their environment and signal across the 
membrane, and growth factor receptors which drive many 
of the key axon signalling pathways. Regenerating axons 
penetrate the extracellular matrix, so integrins which bind 
to extracellular matrix glycoproteins are essential for regen-
eration. In the PNS several integrins are upregulated during 
regeneration and are necessary for axon growth [104]. In 
the CNS overall integrin expression falls with maturity, and 
integrins become selectively excluded from axons (Fig. 1), 
leading to these molecules being at very low levels or absent 
on CNS axons. The main glycoproteins in the mature CNS 
extracellular matrix are tenascin-C and osteopontin, both of 
which are upregulated after injury. The migration-promot-
ing integrin that recognizes these ligands is α9β1 which is 
expressed during development but downregulated in both 
CNS and PNS neurons in adulthood [5]. In addition, the 
two CNS inhibitory molecules NogoA and CSPGs both 
inactivate integrins [61, 128], so the appropriate activated 
integrins are not available to enable axon regeneration. 
Viral expression of α9 integrin together with the integrin 
activator kindlin-1 in DRG neurons enabled long distance 
regeneration of sensory axons in the adult rat spinal cord. 
This demonstrates the principle that providing axons with 
an appropriate adhesion molecule for their environment can 
enable them to grow. However this strategy will not work 
without modification for long-tract CNS neurons, because 
the integrins are selectively excluded from their axons 
(except for some optic nerve axons) [6]. Knowledge of the 
presence of other adhesion molecules on mature CNS axons 
is limited. Type 1 and 2 cadherins and neurexins are present 
in synapses, so they may well be present on axon shafts, and 
other adhesion molecules such as L1 and NCAM are present 
during development, but L1 protein is not detectable in the 
corticospinal tract of adult mice, even when overexpressed 
[67]. Growth factor receptors are drivers of axon signalling 
which can promote growth, but here again some key recep-
tors are excluded from corticospinal axons. Immunostaining 
for both IGF receptor and TrkB showed them to be present 
in proximal corticofugal axons near the cell body, but absent 
in the rest of the axon [58, 59]. Yet these receptors are pre-
sent on developing axons and on the regeneration-competent 
axons of peripheral nerves. We can conclude, therefore, that 
mature CNS axons are lacking some of the key receptors that 
can enable regeneration (Fig. 1). Many adhesion and recep-
tor molecules are present on the cell surface in the context of 
lipid-rich microdomains (rafts), which bring them together 
with signalling and other molecules that act in cis as co-fac-
tors. Reggies/flotillins are raft organizers which are strongly 
upregulated in regenerating fish and frog optic nerves, but 
not after optic nerve damage in mammals. Overexpression 
of reggie-1/flotillin-2 considerably increased regeneration in 
the optic nerve. Another related mechanism relates to gan-
gliosides, glycosphingolipids which are raft components and 
organizers. In peripheral nerve axons, the membrane siali-
dase Neu7 is activated by axotomy to convert much of the 
Fig. 1  Changes in axonal 
transport of growth-related mol-
ecules such as integrins and the 
Rab11 vesicles that transport 
them. During developmental 
growth all neurons transport 
growth-related molecules into 
both axons and dendrites. As 
CNS neurons mature they 
become partitioned into cell 
body, dendritic and axonal 
domains. This partitioning 
achieves specialization of axons 
through selective transport of 
molecules, and many growth-
related molecules are now 
excluded from axons. Sensory 
neurons are not partitioned to 
the same degree and growth-
related molecules continue to 
be transported down axons in 
adulthood
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ganglioside to pro-regenerative GM1, but this does not occur 
in adult retinal axons. Treatment with sialidase can restore 
regeneration to the ganglion cell axons in vitro and to spinal 
cord axons in vivo [70, 145]. Overall, it is clear that the sur-
face of mature CNS axons lacks many of the growth-related 
receptors and structures that are present on the same axonal 
types during development, and on regeneration-competent 
axons in peripheral nerves.
Axonal Transport
In the previous section the selective exclusion of adhesion 
molecules and growth factor receptors from CNS axons is 
described. How does this happen? Selective transport of 
molecules within neurons is part of their differentiation and 
maturation, and many types of molecules are involved [53]. 
As neurons become specialized for their purpose, dendrites 
and axons take on different functions, anatomy and composi-
tion. In order to give axons and dendrites these differences, 
different molecules have to be sent there. A complex set 
of mechanisms has therefore developed to send molecules 
and transport vesicles to the correct place. Some molecules 
are directed into axons or dendrites directly from the Golgi, 
but many are inserted into the membrane of the cell body 
first, then internalized and distributed through the recy-
cling pathway (transcytosis) [75]. A recent genome-wide 
screen for regeneration-related molecules has identified 
transport-related molecules and particularly Rab GTPases 
(molecules that mark and target transport endosomes) as 
determinants of axon regeneration [119]. The differentially 
distributed molecules that have mainly been studied are 
integrins, trks, transferrin receptors (excluded from mature 
axons), L1 (transported into immature axons), glutamate 
receptors (transported to dendrites). Of these, integrins are 
particularly associated with axon growth so I will focus on 
them here. Integrins are present in PNS axons throughout 
life where they participate in regeneration. In the develop-
ing CNS integrins are transported into growing axons and 
are involved in axon growth. In the adult CNS integrins are 
excluded from the axons of cortical and red nucleus pro-
jection axons (Fig. 1), but a few optic nerve axons contain 
integrins. Even when the integrins are overexpressed they 
are still excluded from axons [6]. In cultured CNS neurons, 
cortical and substantia nigra neurons integrins are present 
in immature axons, but become excluded as neurons mature 
[47], and some integrins are present on retinal ganglion 
cell axons cultured from adult retina [137]. Endogenously-
expressed integrins are present at low level, and they do 
not progress past the axon initial segment in cultured cor-
tical neurons, but if the integrins are expressed at a high 
level there is some diffusion into the proximal axons, but 
the integrins are actively transported out of the axons back 
to the cell body. The integrins are mainly transported around 
neurons in recycling endosomes marked by the GTPases 
Rab11 and Arf6, and Rab11 vesicles are also excluded 
from the axons of mature neurons [71]. Live imaging of 
either integrins or Rab11 shows a change in transport with 
maturity. In immature neurons the relatively large amount 
of integrin and endosomes spend roughly equal amounts 
of time moving anterogradely and retrogradely, and this is 
seen also in DRG axons. As the axons mature mostly retro-
grade transport is seen, presumably removing any integrin 
that has diffused into the proximal axons [40, 47, 71]. The 
Rab11 and Arf6 endosomes are part of a complex which 
also contains the transport adapters JIP3/4. The activation 
state of Arf6 determines whether the complex will attach to 
dynein (for retrograde transport) or kinesin (for anterograde 
transport) [93]. The developmental event that changes the 
directionality of transport appears to be the upregulation of 
the Arf6 GEF (activator) Efa6, which accumulates at the 
axon initial segment and leads to Arf6 throughout the axon 
being in the activated (retrograde) state. Removal of Arf6 
or expression of an Arf6 GAP (inactivator) allows integrins 
back into the axons and restores their ability to regenerate 
in the in vitro model; in vivo testing is in progress. In PNS 
axons, although Efa6 is present there is also a large amount 
of the Arf6 GAP ACAP1 which maintains anterograde trans-
port [41]. Overall, the exclusion of adhesion molecules and 
growth factor receptors from mature axons is a major cause 
of their loss of regenerative ability. Restoring integrins to 
axons restores regeneration, but selective transport of other 
receptors needs to be examined in more detail to find out 
how to restore them to axons. Both IGFR-1 and TrkA and 
TrkB are found in Rab11 endosomes [10, 63, 76, 111], so 
some of the same rules that determine integrin localization 
may apply. Integrins, IGF, BDNF and NGF are all powerful 
enablers of axon regeneration, so ensuring sufficient levels 
in CNS axons would be a powerful stimulus to regeneration.
Axonal Signalling
Growth is controlled by various signalling pathways, par-
ticularly those downstream of growth factor receptors (ERK, 
AKT), integrins (FAK), and the small GTPases and calcium. 
Signalling pathways affect all the mechanisms that control 
growth, including the polymerization and motor activity of 
the cytoskeleton, transport, trafficking, membrane addition, 
gene expression and epigenetics. There have been a large 
number of studies of signalling in axon regeneration using 
the various regeneration models in rodents, C. elegans, 
Drosophila and various in vitro models. A few signalling 
mechanisms have proven to be involved in regeneration 
across all these models. RhoA came to prominence because 
it transpired that several inhibitory pathways signalled via 
this route, particularly NogoA and CSPGs, so blocking 
RhoA should neutralize the effects of these regeneration 
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blockers. Some bacteria produce an enzyme C3 transferase 
which inactivates Rho by attaching an ADP-ribose group. A 
cell permeable form of this enzyme was effective in promot-
ing axon regeneration in both the optic nerve and spinal cord 
[77], and Rho kinase inhibitors were also effective [2, 26]. 
Growth factor receptors activate PI3 kinase which phospho-
rylates PIP2 to generate PIP3 which has a powerful stimula-
tory effect on axon growth and other forms of cell migra-
tion. PIP3 has a large number of effects, acting on the many 
proteins with PH or FYVE domains. Many of the effects are 
through activation of the AKT-mTOR pathway, but there 
are also various effects on transport and trafficking [56]. 
The level of PIP3 needs to be closely controlled because 
of its many and powerful effects, and this is achieved by 
balancing synthesis by PI3Kinases and dephosphorylation 
by PTEN and SHIP [72]. Deleting PTEN is therefore a pow-
erful way of increasing and prolonging PIP3 signalling in 
the places where it is generated. PTEN knockout or knock-
down has a strong effect on promoting axon regeneration 
in the optic nerve, and also in the spinal cord [82, 100]. 
However, the effect of PTEN knockout on regeneration is 
much more marked in young animals than in adults, which 
may reflect the maturity-related decline in receptor trans-
port into CNS axons, meaning that there are fewer recep-
tors to activate PI3kinase and generate PIP3. Importantly, 
PTEN knockdown has had synergistic effects with a variety 
of other regeneration-promoting treatments. PTEN knock-
out has a powerful oncogenic effect, so any practical use of 
this method will have to be carefully targeted to neurons. 
The kinase DLK was identified in C. elegans as a required 
component for axon regeneration [55, 144]. In the absence 
of the enzyme axons usually fail completely to regenerate. 
DLK regulates local protein synthesis in axons, particularly 
of the transcription factor CEBP-1 which is then retrogradely 
transported to affect gene expression, and it also influences 
microtubule dynamics, possibly via kinesin-13 [48, 144]. 
In mammals, DLK overactivity leads to axon overgrowth 
suggestive of microtubule overgrowth, and in the retina its 
activity is linked to both apoptosis and regeneration [142]. 
Calcium is central to responses to axotomy. After axotomy 
there is high calcium in the damaged axon tip, due to cal-
cium leaking through the damaged membrane. This and 
other events lead to a more widespread release of calcium 
from internal stores, and the most cut axons fire rapidly for 
a long period allowing yet more calcium to enter the whole 
axon and cell body [21]. These calcium events initiate metal-
loproteinase activity leading to formation of the retraction 
bulb, activate various signalling pathways, and also initiate 
the local translation of proteins which is central to retrograde 
signalling [109]. If sensory axons are cut in a calcium-free 
medium they mostly fail to regenerate [139]. Recently the 
voltage gated calcium channel Alpha2delta2 has been identi-
fied as a repressor of axon regeneration in sensory neurons, 
while deletion of the gene promotes regeneration. Impor-
tantly pregabalin, a widely used pain medication, blocks 
the channel and promotes sensory axon regeneration in the 
spinal cord and peripheral nerves [129]. In addition to the 
examples above, deletion or inhibition of many of the major 
signalling pathways reduces axon regeneration.
Neurotrophins and other trophic factors are powerful 
activators of axonal signalling as long as their receptors 
are present. NT3 has had beneficial effects on corticospinal 
regeneration in the spinal cord [20] and also on regrowth of 
proprioceptive axons [105], and NGF has a strong effect on 
promoting sprouting of sensory axons in the spinal cord, but 
this is not practically useful because it can lead to chronic 
pain [112]. IGF-1 together with ostopontin was a strong 
promoter of optic nerve regeneration [83]. Regeneration in 
the optic nerve has also been increased by CNTF, IL-6, and 
other trophic factors [78, 81]. Stimulation of axon regen-
eration by expression of activated integrin, described ear-
lier, depends on signalling via FAK [28]. An alternative to 
activating receptors is to intervene directly in the signalling 
pathway. Overall, any treatment that promotes axon regener-
ation will modulate signalling pathways in axons. In order to 
drive regeneration with receptor-ligand-induced signalling, 
it will first be necessary to get the receptors to where they are 
needed at the ends of axons. Direct signalling interventions 
have effects on all types of cell, so treatments of this type 
will have to be carefully targeted and controlled.
Local Protein Synthesis
Axon regeneration can only occur if the materials for build-
ing axons are provided. This presents a problem because 
some axons are very long and axonal transport is slow- 
around 25 cm per day at its fastest, so for signals to reach the 
cell body, initiate protein synthesis and for those new pro-
teins to reach the cut axon tip can take a considerable time. 
Regeneration would be more efficient if proteins could be 
synthesized in the axons, and for some axons this certainly 
occurs. This applies also to signals from the damaged axon 
to the cell body, which rely on synthesis of proteins at the 
injury site [109]. In peripheral axons mRNAs are selectively 
transported in axons and the machinery for local synthesis 
and control is present. If local protein synthesis or local pro-
tein degradation is inhibited then axon regeneration is much 
less efficient [139]. The mechanisms behind local synthesis 
are complex. A restricted set of mRNAs are transported into 
sensory axons [54], and they are transported in association 
with a variety of RNA binding proteins recognized by motifs 
on the RNAs, and linked to kinesin [116]. The RNAs can 
be protected from translation as they are transported, for 
instance through binding to ZBP-1 through linkage to the 
cytoskeleton [13, 116] and through the stress granule protein 
G3BP1 [115]. Importantly, the ribonucleoproteins can be 
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localized in the growth cone by interactions with receptors 
for attractant and repellent stimuli [79, 102]. This allows 
local translation to participate in growth cone guidance and 
responses to the environment. Local translation can also 
drive growth cone signalling through local translation of 
mTOR (which also controls synthesis). Also produced are 
retrograde signalling molecules including importin beta and 
STAT3, which control the genetic response to axotomy (see 
below). The mRNAs that are translated include actin, tubu-
lin, GAP-43 and the retrograde signalling molecules [36, 
135]. Local protein synthesis is also a fundamental process 
behind the growth and guidance of axons in development 
[121]. An unresolved question is the extent to which local 
translation occurs in the long-tract axons in the spinal cord 
and elsewhere that are refractory to regeneration. In the CNS 
some axons that have the machinery for local translation 
can regenerate into Schwann cell-containing grafts [68], but 
many of these are probably the central branches of sensory 
axons. Local translation occurs in adult mammalian retinal 
ganglion cell axons (which have relatively high regenerative 
capacity) [121]. If local translation is absent or marginal in 
damaged CNS axons, it is probably the transport and traf-
ficking of the mRNA-protein complexes and the translational 
machinery such as ribosomes that will need attention.
The Axonal Cytoskeleton
Axon growth is driven by the cytoskeleton. Actin dynam-
ics in the filopodia and lamellipodia of the growth cone, 
linked to the environment via adhesion molecules, exerting 
traction on the axon via myosin and reinforced by microtu-
bules are the motor of growth. Many of the processes dis-
cussed above are happening in order to control cytoskeletal 
events. Transport and trafficking also occur in association 
with actin and tubulin [87]. Our knowledge of the detailed 
cytoskeletal events that follow axotomy comes mainly from 
observing the very large axons of aplysia, regeneration in c. 
elegans axons and axotomy of mammalian axons in vitro and 
in vivo [21]. The first event is withdrawal of the cut end of 
the axon followed by formation of a retraction bulb. These 
events are precipitated by a large increase in calcium, enter-
ing the damaged axon from the outside and released from 
internal stores [69]. The calcium triggers various proteases 
which digest cytoskeletal elements and the submembranous 
layer of actin and spectrin. Inside the retraction bulb are 
randomly arranged microtubules and accumulations of trans-
port vesicles [30, 38, 39]. Soon new microtubules start to be 
formed, visualised by an increase in the number of tubules 
capped by end-binding proteins, and actin filaments reap-
pear [30]. In axons that are capable of regeneration a new 
growth cone is formed that is similar to developmental-type 
growth cones, but in regeneration-incompetent axons (which 
mainly means those of the mammalian CNS), the retraction 
bulb continues to be dynamic for many hours, but does not 
generate a new growth cone [71, 132, 139]. For regenera-
tion to proceed, new cytoskeletal molecules are required. 
In some axons these can be produced by local translation 
(see above) [36, 140], for polymers such as actin filaments 
and microtubules local recycling can occur, and in axons 
that regenerate there is an overall increase in axonal trans-
port bringing many molecules to the growing axon tip [8, 
88, 97]. Modification of the cytoskeletal events following 
axonal damage can be beneficial. Taxol and epothilone B are 
microtubule-stabilising compounds which can reduce retrac-
tion and retraction bulb formation, and can enhance regen-
eration of sensory and serotinergic CNS axons after spinal 
cord injury. Conversely depolymerising microtubules with 
nocodazole turns cut sensory axon tips into sterile retrac-
tion bulbs that fail to regenerate [39, 114]. There are many 
controls of cytoskeletal behaviour, but some molecules stand 
out. Efa6 was mentioned above because of the part it plays in 
excluding molecules from axons. In C.elegans it has a direct 
effect on restraining microtubule dynamics. A large screen 
to find molecules that affect regeneration [29, 96] came up 
as expected with many molecules that reduce regeneration 
if they are absent, but much rarer are molecules such as 
Efa6 whose absence enhances regeneration and therefore are 
functional and regeneration suppressors. Efa6 clearly gives 
excessive microtubule stabilisation. A number of molecules 
affect microtubule dynamics by binding to them and having 
the ability to sever the microtubules, spastin atlastin fidgetin 
and katanin are examples. The level of these molecules is 
critical: in Drosophila if levels of spastin and atlastin are 
too high or too low regeneration fails [107], and fidgetin is a 
regeneration inhibitor [89]. Kinesins are generally thought of 
as transport molecules, but some can also affect microtubule 
dynamics. Kinesin-13 is a tubulin depolymerizing molecule 
regulated by DLK-1 (see above), which can restrict micro-
tubule growth after axotomy, and kinesin Kif3C is binds to 
microtubule end-binding proteins where it affects microtu-
bule dynamics and is necessary for regeneration in mam-
malian sensory axons [52]. Microtubules are modified in 
various ways, particularly by tyrosination and acetylation. 
Tyrosinated microtubules turn over faster than detryrosi-
nated, and acetylation is associated with stable older micro-
tubules and deacetylation increases microtubule dynamics. 
In growing axons the more dynamic microtubules are seen 
at the growth cone. The histone deacetylase HDAC5 is an 
important player in peripheral nerve regeneration. After 
axotomy it is localized to the cut axon by association with 
the actin-binding protein filamin A, and at the same time it 
leave the nucleus enabling epigenetic changes (see later). 
In the axons it decetylates microtubules, promoting micro-
tubule dynamics and assisting regeneration, but a similar 
effect in CNS neurons has not been found [31]. Growing 
axon tips have tyrosinated dynamic microtubules [12, 39]. 
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Reduced detyrosination has been associated with enhanced 
regeneration in the optic nerve, sciatic nerve and in sensory 
axons through the interaction with Kif3C [49, 52]. Overall, 
the cytoskeleton is the motor of axon growth, and there are 
several types of intervention that can affect regeneration. 
Of these the most practical is microtubule stabilization with 
epothilone-B, which has the added advantage that it modifies 
the glial reaction to injury.
Genetics and Epigenetics
Damage to peripheral nerves results in the initiation of a 
regenerative programme, with upregulation of many genes. 
A peripheral nerve crush will initiate this genetic pro-
gramme, and a subsequent lesion of sensory axons in the spi-
nal cord will lead to a more vigorous regeneration response 
than the same spinal lesion without a previous peripheral 
lesion [95]. Similarly, a second lesion to the peripheral axons 
will lead to faster regeneration than if there had been no 
previous lesion. This is known as the conditioning effect. 
Damage to the central branch of the sensory axons alone 
does not initiate this same pattern of upregulation of gene 
expression, and neither do lesions to intrinsic CNS axons. 
The PNS axotomy response and the conditioning effect 
that it produces has therefore been used as a model for the 
genetic changes that should drive enhanced regeneration of 
axons [11].
The regeneration response is driven by retrograde signals 
from the site of axotomy, and can also be initiated to some 
extent by local inflammatory and cytokine effects in the 
dorsal root ganglia. The early retrograde signal is calcium. 
Calcium is initially greatly increased through leakage at the 
injury site, and this leads to more widespread release of cal-
cium from internal stores. The lesion and its effects also usu-
ally lead to rapid firing of the damaged axons, leading to fur-
ther calcium entry. These stimuli lead to expression changes 
in the cell body, and also activation of signalling pathways 
and initiation of local translation at the injury to produce 
retrograde signals, leading to retrograde transport of STAT3, 
DLK, JNK in association with importin-beta and vimentin 
[15]. Several cytokines, including IL-6, LIF and CNTF are 
also upregulated [25, 120, 125]. The result is upregulation of 
more than 1000 genes in sensory neurons. However axotomy 
can also have non-specific negative effects on translation 
through released ribonucleases, which can modify rough 
endoplasmic reticulum, degrade ribosomes and monoribo-
somes [94]. Of these interest has focused particularly on 
transcription factors that may orchestrate the programme. 
A recent bioinformatics study has identified a core group 
of these, ATF3, EGR1, FOS, JUN, MYC, RELA, SMAD1 
and STAT3 that are expressed and positioned in the control 
network to be the controllers of the axotomy response [27]. 
The large majority of these changes in gene expression do 
not occur after axotomy of the CNS branch of sensory axons 
or after lesions of intrinsic CNS axons. The logical next 
step is to express one or more of these transcription factors 
in sensory or CNS neurons in order to activate a regenera-
tion programme and enable axon regeneration in peripheral 
nerves and in the CNS. Expression of single transcription 
factors has led to some increase in regeneration, so expres-
sion of multiple factors has been tried. For instance expres-
sion of ATF3 increased speed of regeneration in peripheral 
nerves, but marginally enabled regeneration in the spinal 
cord. A combination of four transcription factors, ATF3, 
SMAD1, STAT3 and c-Jun was no more effective that ATF3 
alone [42]. In the CNS the results of transcription factor 
manipulation have shown some increase in regeneration. Of 
the transcription factors listed above involved in the sen-
sory neuron axotomy response, overexpression of an active 
form of STAT3 enhanced corticospinal tract sprouting and 
slightly increased optic nerve regeneration [74, 90], activa-
tion of the SMAD1 pathway enhanced regeneration in the 
optic nerve and spinal cord [131]. The conclusion is that the 
injury response in sensory neurons clearly enhances regen-
eration, because it enables increased growth when sensory 
axons are cut in the spinal cord and faster regeneration in 
peripheral nerves. However, simply expressing some of the 
transcription factors does not have as strong an effect on 
regeneration as peripheral nerve lesions, and expressing the 
transcription factors in CNS neurons has only a small effect 
on their ability to regenerate.
A similar logic applies to the study of genetic changes 
during neuronal maturation. It is clear that neurons lose 
intrinsic regenerative ability with maturity, so study of the 
genetic changes during maturation and attempting to reverse 
these changes by expressing or knocking down transcription 
factors whose expression has changed during maturation is 
a logical step. Research activity in this area has focused on 
the Kruppel-like factor (KLF) family of transcription factors. 
Several of these change their expression during maturation. 
Deletion KLF9 or overexpression of KLF6 or KLF7 has 
positive effects on regeneration in the spinal cord and optic 
nerve [9, 19, 133]. Also p53 expression increased corticospi-
nal regeneration [45], but again these interventions do not 
restore the neurons to their embryonic level of regenerative 
ability.
The results above are sufficient to demonstrate that 
manipulating transcription factor expression in mature neu-
rons can have effects on axon regeneration. However, the 
effects are relatively modest. Expression of only two to four 
transcription factors in fibroblasts is sufficient to return them 
to a stem cell state as iPS cells, but rejuvenating neurons 
seems to be much more difficult. An important difference is 
that the fibroblasts are dividing and neurons are not. During 
mitosis the chromatin is opened up and histones removed, 
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making many areas of chromatin accessible that were previ-
ously hidden. This has been called mitotic advantage. When 
non-dividing nuclei are placed in oocytes their pattern of 
gene expression changes much less than dividing nuclei, 
and many transcription factor binding sites only become 
accessible during mitosis. A major mechanism for masking 
transcription factor binding sites is binding to the chromatin 
of modified histones [92], and methylation of DNA is also 
involved. In mature neurons a similar masking of chromatin 
sites appears to prevent expressed transcription factors from 
having the intended effects on regeneration. Recent research 
has started to address these issues. There is evidence that 
the expression of the regeneration-associated genetic pro-
gramme in sensory neurons, triggered by axotomy, is made 
possible by epigenetic changes that open up interaction 
sites. There are many histones, each subject to many types 
of modification that affect their chromatin binding. The best 
understood regulation of histones is by acetylation, medi-
ated by histone acetyltransferases (HATs) and histone dea-
cetylases (HDACs). Two examples of changes in histone 
acetylation after peripheral axotomy are understood in some 
detail. HDAC5 is usually found in sensory neuron nuclei, 
but after axotomy it is exported into the cytoplasm and the 
axons. The trigger is calcium via protein kinase C. HDAC5 
in the axon affects microtubule acetylation as described 
above, while removing HDAC5 from the nucleus enables 
expression of the early response genes of the regeneration 
transcription programme, and without HDAC5 export regen-
eration is inhibited [31]. There are also changes in HATs. 
The HAT histone acetyltransferase p300/CBP-associated 
factor (PCAF) is activated by ERK signalling after injury, 
and the PCAF then modifies histones at the promoters of 
some key regeneration-related genes. Without PCAF activ-
ity the conditioning effect and regeneration of sensory axons 
in the spinal cord is not seen [103]. Histone acetylation via 
Creb-binding protein (Cbp) is also the link between reha-
bilitation activity and expression of the regenerative pro-
gramme in DRG neurons [64]. These changes in HDACs 
and HATs do not occur after axotomy in the CNS. A recent 
focus has been to try to rejuvenate mature CNS neurons, 
bringing back the regenerative ability that they had during 
embryogenesis, and, as described above, some success has 
been obtained by modulating the expression of KLF tran-
scription factors and combining KLF9 deletion with JNK3 
produces an additive effect [9]. However the general finding 
has been that it has not been possible to reawaken the axon 
growth programme through expression of transcription fac-
tors. The problem appears to be one of epigenetics. During 
CNS cortical neuronal maturation there is a major change 
in the accessible regions of the genome, with only 30% of 
accessible sites being available at both immature and mature 
stages. Many of the genes that become masked in adult-
hood were related to axon growth, while the genes that were 
available at both stages were mostly related to homeostasis, 
vesicular transport and ion transport. Two pro-regenerative 
transcription factors whose target genes are accessible in 
mature neurons in the cortex (KLF7 and STAT3) were suc-
cessful at increasing corticspinal tract regeneration, while 
two factors with inaccessible targets (JUN and STAT3) 
did not promote regeneration when expressed [138]. What 
might drive these maturational changes in gene expression 
and and epigenetics? Many of the changes described above 
occur at the same time as axons have reached their targets 
and synapses are forming and maturing. Signalling to the 
nucleus from the postsynaptic side of synapses in dendrites 
or from the presynaptic side in axons is a strong candidate, 
and several signalling pathways that affect neuronal gene 
expression have been identified which would be candidates 
for driving the neuronal maturation process [57, 99]. Over-
all, it appears that for neurons to express a regeneration tran-
scriptional programme the right transcription factors must be 
expressed and present in the nucleus. However the presence 
of the transcription factors is not enough, the promoters and 
enhancers that drive the regeneration programme must be 
accessible. In sensory neurons the effects of axotomy reveal 
some of the key promoters and enhancers, so they can enter 
a regeneration-competent state. In CNS neurons many of the 
key promoters and enhancers are hidden, and the signalling 
events that follow CNS axotomy do not initiate events to 
reveal them. In order to drive regeneration of CNS neurons 
we will need to understand how to manipulate these epige-
netic events that block transcription of the key regeneration 
genes.
Perspectives
I started this article by asking why it has been so difficult and 
taken so long to find out how to regenerate axonal pathways 
in the CNS. The sections above demonstrate how complex 
regeneration is, and how many interventions have had sig-
nificant but insufficient effects on stimulating regeneration. 
Why has the problem turned out to be so complicated? When 
research on this subject started to investigate mechanisms in 
the 1980s there was an assumption that regeneration would 
largely recapitulate development, and that one or two inhibi-
tory mechanisms would need to be corrected. It has turned 
out that regeneration is very different to embryonic devel-
opment, and that there are a large number of mechanisms 
that block regeneration and repair. There must be significant 
evolutionary benefits in restriction regeneration, as argued 
above, so evolution has gone about turning off regeneration 
in the usual way. Human engineers when they want to solve 
a problem look for a single elegant and powerful solution. 
Evolution hardly ever works this way. Because it has to work 
with random events that must give selective advantage, it 
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tends to end up solving problems by creating several paral-
lel mechanisms, often individually not very efficient, which 
together add up to a robust and failure-proof solution. It 
seems likely that turning off regeneration and repair has 
gone this way, with the many mechanisms above as the con-
sequence. How are we to repair the damaged CNS? It will 
almost certainly not be necessary to address all the poten-
tial inhibitory mechanisms. For instance it is encouraging 
that the fairly simple single intervention of expressing an 
appropriate integrin and integrin activator was able to pro-
mote long distance sensory regeneration. For CNS neurons 
the problem is more difficult because of the suppression of 
the regeneration transcriptional programme, and because 
the neurons are partitioned to exclude many growth related 
molecules from mature axons. From a practical perspec-
tive it seems sensible to work both on the axons, restoring 
transport and trafficking of the key molecules, and on the 
transcriptional programme in cell bodies. If we can arrange 
for expression of the right molecules and then get them to 
the right place, then axons will regenerate.
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